Choksi Laboratories Approves Rs 6.2 Crore Promoter Warrants At Rs 177

Board approved issue of 3.5 lakh warrants at Rs 177 each aggregating Rs 6.19 Cr to Sunil, Himika and Stela Choksi, convertible into equity in 18 months, subject to EGM on 17 Oct 2026. First equity infusion on record for the deleveraging, no-dividend testing business to fund ongoing capacity expansion; all-promoter allotment tightens family control of board and management. Adds growth capital with 25% upfront; use of proceeds, pricing vs market and dilution impact pending disclosure; EGM and regulatory approvals required; allottees are promoter family including CFO.